Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today


Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade around $62. At Friday's prices, a paltry $100 investment in 2022 would have grown to more than $2,700!

Is there still time for you to take advantage? Absolutely.

Viking develops therapies to treat obesity. Two of its drug candidates -- VK2809 and VK2735 -- are currently in phase 2 trials, with promising early results. Patients using VK2735, for example, experienced a mean body weight reduction of up to 15% in just 13 weeks.

Continue reading


Source Fool.com

Viking Therapeutics Inc Aktie

46,56 €
-4,65 %
Starke Verluste bei Viking Therapeutics Inc heute, der Kurs fällt um -4,65 %.

Like: 0
Teilen

Kommentare